[{"NetIncomeLoss_1_Q1_USD":-8082000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":2140000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":9151000.0,"InterestPaidNet_1_Q1_USD":638000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-907000.0,"Depreciation_1_Q1_USD":384000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1343700.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-751000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":1259000.0,"AssetsCurrent_0_Q1_USD":24034000.0,"OperatingLeaseExpense_1_Q1_USD":319000.0,"LongTermDebt_0_Q1_USD":34626000.0,"LongTermDebtCurrent_0_Q1_USD":1238000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":8179000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":399000.0,"DebtInstrumentUnamortizedDiscount_0_Q1_USD":489000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":31672608.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":44000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":1219000.0,"Assets_0_Q1_USD":74481000.0,"ShareBasedCompensation_1_Q1_USD":254000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":6.96,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1300000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1256000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":12212000.0,"OperatingIncomeLoss_1_Q1_USD":-5401000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":2706133.0,"InventoryNet_0_Q1_USD":4718000.0,"DepreciationAndAmortization_1_Q1_USD":1009000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":11691000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":3192000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":7262000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":5262000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":2195000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":48000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":772000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-66000.0,"AccountsReceivableNetCurrent_0_Q1_USD":6590000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.51,"IncomeTaxExpenseBenefit_1_Q1_USD":-6000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"WarrantsAndRightsOutstanding_0_Q1_USD":192000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1041000.0,"ContractWithCustomerAssetNet_0_Q1_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-4000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":426000.0,"TemporaryEquityAccretionToRedemptionValueAdjustment_1_Q1_USD":296000.0,"FairValueAdjustmentOfWarrants_1_Q1_USD":1870000.0,"OtherAssetsCurrent_0_Q1_USD":1035000.0,"IncreaseDecreaseInInventories_1_Q1_USD":430000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-9568000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":702000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":554000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.01,"OtherAssetsNoncurrent_0_Q1_USD":1642000.0,"Liabilities_0_Q1_USD":64184000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"DebtInstrumentFeeAmount_0_Q1_USD":1625000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":4116000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2648000.0,"Goodwill_0_Q1_USD":18262000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-8088000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":254000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-4404000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":2740000.0,"SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent_0_Q1_USD":2360000.0,"CostOfRevenue_1_Q1_USD":4807000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":1179000.0,"LiabilitiesCurrent_0_Q1_USD":20558000.0,"AccountsPayableCurrent_0_Q1_USD":5776000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":12193000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":44000.0,"LongTermDebtNoncurrent_0_Q1_USD":33388000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":3336000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":22160000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"GrossProfit_1_Q1_USD":7405000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":1.53,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":22160000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":160000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":884000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":6260000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":6053000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":2140000.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q1_pure":0.0785,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":2139000.0,"RestrictedCashNoncurrent_0_Q1_USD":502000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":14.25,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":27422000.0,"TemporaryEquityAccretionOfDividends_1_Q1_USD":1190000.0,"PreferredStockValue_0_Q1_USD":1253000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-10000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":74481000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":2002000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":254000.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":106000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":8701000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":1661000.0,"OperatingExpenses_1_Q1_USD":12806000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":906000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.54,"DeferredOfferingCosts_0_Q1_USD":1439000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":277000.0,"StockholdersEquity_0_Q1_USD":-60000000.0,"RedeemablePreferredStockDividends_1_Q1_USD":1190000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":1059000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":907000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":34976000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":80000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-61254000.0,"DividendsPreferredStock_1_Q1_USD":1190000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-5315000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":120000.0,"ProfitLoss_1_Q1_USD":-8082000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":323000.0,"Ticker":"AKYA","CIK":"1711933","name":"AKOYA BIOSCIENCES, INC.","OfficialName":"Akoya BioSciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"413727411.0","Country":"United States","Sector":"Capital Goods","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20210519"}]